Admission Date: [**2178-1-20**]        Discharge Date: [**2178-2-7**]  Date of Birth:  [**2107-2-15**]        Sex:  M  Service:  OME   HISTORY OF PRESENT ILLNESS:  This patient is a 70-year-old male with extensive locally recurrent melanoma involving his face, status post excision, neck dissection and radiation therapy.
He was due to be started on high-dose IL-2 but in clinic on [**2178-1-12**], he was noticed to have erythema in an area of recent lymph node dissection felt consistent with cellulitis, and was started on oral Keflex, and now is presenting with worsening erythema.
On [**2177-8-21**] he underwent wide local excision and sentinel lymph node biopsy, with melanoma present in 1 left intraparotid node.
He underwent radiation therapy to the forehead area, completing 20 fractions over 4 weeks.
In late [**2177-10-6**] a PET CT showed increased glucose uptake at sites of surgery on his thigh and around the superior edge of the graft on his face.
The BRCA mutation testing on his tumor was negative.
He has passed screening tests to begin high-dose IL-2 therapy.
MEDICATIONS ON ADMISSION:  Enalapril 20 mg p.o.
daily, pravastatin 20 mg p.o.
daily, Keflex 500 mg p.o.
Left temporal and buccal graft without erythema.
HOSPITAL COURSE:  The patient was admitted with cellulitis and was placed on IV vancomycin.
Doxycycline was added when he did not appear to be improving.
Transthoracic echo revealed diastolic heart failure and he was continued on enalapril and Lasix.
He had an ID consult on [**1-28**] who suggested stopping the Unasyn, changing to cefepime and adding vancomycin back.
He was treated with Lasix with improvement in his respiratory status.
He developed SVT to the 140s on [**2178-2-4**], which spontaneously improved with a fluid bolus.
Lasix and enalapril were continued and he was weaned to room air with O2 saturations in the mid 90s.
Other side effects related to IL-2 included rigors improved with Demerol; fatigue; and hypotension on treatment day 3, requiring fluid boluses.
IV fluids were continued given acute renal failure.
He was anemic and was transfused with packed red blood cells with discharge hemoglobin of 9.1.
Metastatic melanoma status post cycle 1, week 1, high-     dose IL-2 therapy complicated by pulmonary edema, and     bilateral pleural effusions from IL-2 induced capillary     leak, with respiratory distress.
DISCHARGE MEDICATIONS:  Enalapril 20 mg p.o.
daily, Lasix 20 mg p.o.
daily, lorazepam 0.5 mg q.
nausea, pravastatin 20 mg p.o.
daily, Compazine 5 to 10 mg q.i.d.
FOLLOW-UP PLANS:  The patient will return to clinic on [**2178-2-10**] for assessment of his clinical status prior to consideration for treatment with week #2 of therapy.
I have reviewed the discharge summary and agree with the hospital course and disposition as dictated by [**First Name8 (NamePattern2) 622**] [**Last Name (NamePattern1) 17265**].
